Variant report
Variant | nsv526816 |
---|---|
Chromosome Location | chr5:29301769-29313442 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560724806 | chr5:29304646-29304647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528028008 | chr5:29304690-29304691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs55897959 | chr5:29304727-29304728 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs143382477 | chr5:29304730-29304731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376688003 | chr5:29304754-29304755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550121810 | chr5:29304755-29304756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192939754 | chr5:29304774-29304775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571678722 | chr5:29304814-29304815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532623985 | chr5:29304828-29304829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150594102 | chr5:29304845-29304846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565869765 | chr5:29304853-29304854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536410512 | chr5:29304904-29304905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561908497 | chr5:29304929-29304930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35166177 | chr5:29304936-29304937 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs569935866 | chr5:29304971-29304972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs57945511 | chr5:29305026-29305027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558507302 | chr5:29305034-29305035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576902338 | chr5:29305036-29305037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6865945 | chr5:29305055-29305056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570541905 | chr5:29305071-29305072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114935496 | chr5:29305104-29305105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572317440 | chr5:29305127-29305128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542780515 | chr5:29305135-29305136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184579046 | chr5:29305155-29305156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531864420 | chr5:29305158-29305159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139596419 | chr5:29305173-29305174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567409709 | chr5:29305179-29305180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs199824042 | chr5:29305191-29305192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532356133 | chr5:29305192-29305193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547878405 | chr5:29305193-29305194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534623935 | chr5:29305208-29305209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529935103 | chr5:29305246-29305247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149722518 | chr5:29305259-29305260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369354869 | chr5:29305278-29305279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188288661 | chr5:29305302-29305303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537340865 | chr5:29305330-29305331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373347186 | chr5:29305381-29305382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553795042 | chr5:29305418-29305419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181075278 | chr5:29305436-29305437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185283245 | chr5:29305437-29305438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534284726 | chr5:29305438-29305439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115484132 | chr5:29305443-29305444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553050988 | chr5:29305483-29305484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189613094 | chr5:29305486-29305487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542842091 | chr5:29305504-29305505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141542047 | chr5:29305509-29305510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145561832 | chr5:29305557-29305558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182019669 | chr5:29305569-29305570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544092410 | chr5:29305622-29305623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565398435 | chr5:29305630-29305631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29304600-29305200 | Enhancers | Hela-S3 | cervix |
2 | chr5:29305200-29305600 | Weak transcription | Hela-S3 | cervix |
3 | chr5:29305600-29308400 | Enhancers | Hela-S3 | cervix |